“Enjoy glass of wine before eating: ” a randomized trial to test the orexigenic effects of this advice in advanced cancer patients

Aminah Jatoi, Rui Qin, Daniel Satele, Shaker Dakhil, Pankaj Kumar, David B. Johnson, Sachdev P. Thomas, Philip J. Stella, Jose Castillo, Min Li, Martin E Fernandez-Zapico

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: Because the extant literature suggests wine increases appetite, this study sought to determine whether this effect could be observed in advanced cancer patients with appetite loss. Methods: Advanced cancer patients with self-reported loss of appetite were randomly assigned to white wine with ≤15 % alcohol content twice a day for 3–4 weeks versus a nutritional supplement, such as Boost® or Ensure®. Patients assigned to wine were encouraged to also take a nutritional supplement, whereas patients assigned to the nutritional supplement arm were told to abstain completely from alcohol. Patient-reported outcomes were captured with a validated questionnaire to assess the primary endpoint of appetite improvement. Results: A total of 141 patients (118 evaluable) were enrolled. Twenty-eight patients (48 %) in the wine arm reported an improvement in appetite at some point during the treatment period, whereas 22 patients (37 %) assigned to the nutritional supplement arm also reported improvement (p = 0.35). Other appetite-related questions and questionnaire items showed no statistically significant differences between treatment arms. In both arms, approximately 9 % of patients achieved weight stability (p = 0.98); median survival was not statistically different. Both interventions were well tolerated. Conclusion: As prescribed in this trial, wine does not improve appetite or weight in advanced cancer patients.

Original languageEnglish (US)
Pages (from-to)1-8
Number of pages8
JournalSupportive Care in Cancer
DOIs
StateAccepted/In press - Apr 2 2016

Fingerprint

Wine
Glass
Appetite
Eating
Neoplasms
Alcohols
Weights and Measures
Survival
Therapeutics

Keywords

  • Anorexia
  • Appetite
  • Cancer
  • Hunger
  • Weight loss

ASJC Scopus subject areas

  • Oncology

Cite this

“Enjoy glass of wine before eating : ” a randomized trial to test the orexigenic effects of this advice in advanced cancer patients. / Jatoi, Aminah; Qin, Rui; Satele, Daniel; Dakhil, Shaker; Kumar, Pankaj; Johnson, David B.; Thomas, Sachdev P.; Stella, Philip J.; Castillo, Jose; Li, Min; Fernandez-Zapico, Martin E.

In: Supportive Care in Cancer, 02.04.2016, p. 1-8.

Research output: Contribution to journalArticle

Jatoi, Aminah ; Qin, Rui ; Satele, Daniel ; Dakhil, Shaker ; Kumar, Pankaj ; Johnson, David B. ; Thomas, Sachdev P. ; Stella, Philip J. ; Castillo, Jose ; Li, Min ; Fernandez-Zapico, Martin E. / “Enjoy glass of wine before eating : ” a randomized trial to test the orexigenic effects of this advice in advanced cancer patients. In: Supportive Care in Cancer. 2016 ; pp. 1-8.
@article{daf1cc65095448f69f48471ecb309a00,
title = "“Enjoy glass of wine before eating: ” a randomized trial to test the orexigenic effects of this advice in advanced cancer patients",
abstract = "Background: Because the extant literature suggests wine increases appetite, this study sought to determine whether this effect could be observed in advanced cancer patients with appetite loss. Methods: Advanced cancer patients with self-reported loss of appetite were randomly assigned to white wine with ≤15 {\%} alcohol content twice a day for 3–4 weeks versus a nutritional supplement, such as Boost{\circledR} or Ensure{\circledR}. Patients assigned to wine were encouraged to also take a nutritional supplement, whereas patients assigned to the nutritional supplement arm were told to abstain completely from alcohol. Patient-reported outcomes were captured with a validated questionnaire to assess the primary endpoint of appetite improvement. Results: A total of 141 patients (118 evaluable) were enrolled. Twenty-eight patients (48 {\%}) in the wine arm reported an improvement in appetite at some point during the treatment period, whereas 22 patients (37 {\%}) assigned to the nutritional supplement arm also reported improvement (p = 0.35). Other appetite-related questions and questionnaire items showed no statistically significant differences between treatment arms. In both arms, approximately 9 {\%} of patients achieved weight stability (p = 0.98); median survival was not statistically different. Both interventions were well tolerated. Conclusion: As prescribed in this trial, wine does not improve appetite or weight in advanced cancer patients.",
keywords = "Anorexia, Appetite, Cancer, Hunger, Weight loss",
author = "Aminah Jatoi and Rui Qin and Daniel Satele and Shaker Dakhil and Pankaj Kumar and Johnson, {David B.} and Thomas, {Sachdev P.} and Stella, {Philip J.} and Jose Castillo and Min Li and Fernandez-Zapico, {Martin E}",
year = "2016",
month = "4",
day = "2",
doi = "10.1007/s00520-016-3190-6",
language = "English (US)",
pages = "1--8",
journal = "Supportive Care in Cancer",
issn = "0941-4355",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - “Enjoy glass of wine before eating

T2 - ” a randomized trial to test the orexigenic effects of this advice in advanced cancer patients

AU - Jatoi, Aminah

AU - Qin, Rui

AU - Satele, Daniel

AU - Dakhil, Shaker

AU - Kumar, Pankaj

AU - Johnson, David B.

AU - Thomas, Sachdev P.

AU - Stella, Philip J.

AU - Castillo, Jose

AU - Li, Min

AU - Fernandez-Zapico, Martin E

PY - 2016/4/2

Y1 - 2016/4/2

N2 - Background: Because the extant literature suggests wine increases appetite, this study sought to determine whether this effect could be observed in advanced cancer patients with appetite loss. Methods: Advanced cancer patients with self-reported loss of appetite were randomly assigned to white wine with ≤15 % alcohol content twice a day for 3–4 weeks versus a nutritional supplement, such as Boost® or Ensure®. Patients assigned to wine were encouraged to also take a nutritional supplement, whereas patients assigned to the nutritional supplement arm were told to abstain completely from alcohol. Patient-reported outcomes were captured with a validated questionnaire to assess the primary endpoint of appetite improvement. Results: A total of 141 patients (118 evaluable) were enrolled. Twenty-eight patients (48 %) in the wine arm reported an improvement in appetite at some point during the treatment period, whereas 22 patients (37 %) assigned to the nutritional supplement arm also reported improvement (p = 0.35). Other appetite-related questions and questionnaire items showed no statistically significant differences between treatment arms. In both arms, approximately 9 % of patients achieved weight stability (p = 0.98); median survival was not statistically different. Both interventions were well tolerated. Conclusion: As prescribed in this trial, wine does not improve appetite or weight in advanced cancer patients.

AB - Background: Because the extant literature suggests wine increases appetite, this study sought to determine whether this effect could be observed in advanced cancer patients with appetite loss. Methods: Advanced cancer patients with self-reported loss of appetite were randomly assigned to white wine with ≤15 % alcohol content twice a day for 3–4 weeks versus a nutritional supplement, such as Boost® or Ensure®. Patients assigned to wine were encouraged to also take a nutritional supplement, whereas patients assigned to the nutritional supplement arm were told to abstain completely from alcohol. Patient-reported outcomes were captured with a validated questionnaire to assess the primary endpoint of appetite improvement. Results: A total of 141 patients (118 evaluable) were enrolled. Twenty-eight patients (48 %) in the wine arm reported an improvement in appetite at some point during the treatment period, whereas 22 patients (37 %) assigned to the nutritional supplement arm also reported improvement (p = 0.35). Other appetite-related questions and questionnaire items showed no statistically significant differences between treatment arms. In both arms, approximately 9 % of patients achieved weight stability (p = 0.98); median survival was not statistically different. Both interventions were well tolerated. Conclusion: As prescribed in this trial, wine does not improve appetite or weight in advanced cancer patients.

KW - Anorexia

KW - Appetite

KW - Cancer

KW - Hunger

KW - Weight loss

UR - http://www.scopus.com/inward/record.url?scp=84962034252&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962034252&partnerID=8YFLogxK

U2 - 10.1007/s00520-016-3190-6

DO - 10.1007/s00520-016-3190-6

M3 - Article

C2 - 27039205

AN - SCOPUS:84962034252

SP - 1

EP - 8

JO - Supportive Care in Cancer

JF - Supportive Care in Cancer

SN - 0941-4355

ER -